• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION DYNAGEN CRT-D; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION DYNAGEN CRT-D; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D Back to Search Results
Model Number G154
Device Problems High impedance (1291); Noise, Audible (3273)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 06/19/2021
Event Type  Injury  
Manufacturer Narrative
The local area field representative was contacted for additional information.If information is provided in the future, a supplemental report will be issued.
 
Event Description
It was reported that this cardiac resynchronization therapy defibrillator (crt-d) and implantable right ventricular (rv) defibrillation lead triggered an alert and started beeping due to out-of-range shock impedance measurements greater than 125 ohms.This crt-d and rv lead remain in service.No adverse patient effects were reported.
 
Event Description
It was reported that this cardiac resynchronization therapy defibrillator (crt-d) and implantable right ventricular (rv) defibrillation lead triggered an alert and started beeping due to out-of-range shock impedance measurements greater than 125 ohms.This crt-d and rv lead remain in service.No adverse patient effects were reported.Additional information received indicated that shock configuration was changed to coil to can, and shock impedance measurements within normal limits were observed.The patient had no arrhythmias or complaints.Patient was non-ischemic.The physician ordered an echo and results were normal.The device was deactivated pending lead revision.This right ventricular (rv) lead was later surgically abandoned and replaced.This cardiac resynchronization therapy defibrillator (crt-d) remains in service.No additional adverse patient effects were reported.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DYNAGEN CRT-D
Type of Device
DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
MDR Report Key12185214
MDR Text Key262164221
Report Number2124215-2021-19300
Device Sequence Number1
Product Code NIK
UDI-Device Identifier00802526534652
UDI-Public00802526534652
Combination Product (y/n)N
PMA/PMN Number
P010012/S341
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 10/10/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date11/10/2018
Device Model NumberG154
Device Catalogue NumberG154
Device Lot Number101784
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 06/25/2021
Initial Date FDA Received07/16/2021
Supplement Dates Manufacturer Received07/14/2021
Supplement Dates FDA Received10/10/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age52 YR
-
-